Testing effectiveness (Phase 2)Study completedNCT00841516
What this trial is testing
Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative
Who this might be right for
Allergic Rhinoconjunctivitis
Allergopharma GmbH & Co. KG 14